MYnd Analytics Inc (NASDAQ:MYND) Director John Pappajohn acquired 10,000 shares of MYnd Analytics stock in a transaction dated Friday, January 5th. The shares were bought at an average cost of $3.44 per share, with a total value of $34,400.00. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.
MYnd Analytics Inc (NASDAQ:MYND) opened at $3.22 on Wednesday. MYnd Analytics Inc has a twelve month low of $2.80 and a twelve month high of $9.45. The stock has a market capitalization of $14.21, a price-to-earnings ratio of -1.27 and a beta of 1.15.
Separately, Maxim Group set a $18.00 target price on MYnd Analytics and gave the stock a “buy” rating in a report on Saturday, November 25th.
TRADEMARK VIOLATION NOTICE: This piece was first posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://transcriptdaily.com/2018/01/10/john-pappajohn-buys-10000-shares-of-mynd-analytics-inc-mynd-stock.html.
About MYnd Analytics
MYnd Analytics, Inc, formerly CNS Response, Inc, is a predictive analytics company. The Company has developed a decision support tool to help physicians reduce trial and error treatment in mental health, and provide personalized care to patients. The Company provides objective clinical decision support to mental healthcare providers for the personalized treatment of behavioral disorders, including depression, anxiety, bipolar disorder, post-traumatic stress disorder (PTSD) and other non-psychotic disorders.
Receive News & Ratings for MYnd Analytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MYnd Analytics and related companies with MarketBeat.com's FREE daily email newsletter.